Fedratinib in patients with myelofibrosis previously treated with ruxolitinib: an updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failure - Harrison, C N; Schaap, N; Vannucchi, A M (Am J Hematol, 2020)